Drug Shortages Demand Action: Policy Changes to Protect Patient Care
Throughout the past few years, the oncologic community has been plagued with drug shortages, most recently affecting platinum-based therapies. In January 2023, the US Food and Drug Administration (FDA) completed an inspection on an Intas platinum-drug production plant in India and reported several concerns ranging from record keeping to drug quality. 1 The company was issued an FDA Warning Letter in July. 1 As a result, production for carboplatin was suspended, causing US-based supply to drop. 2 As
